| Issue Date | Title | Author(s) | Source | scopus | WOS | Fulltext/Archive link |
| 2017 | Adipose-Derived Stem Cells Protect Skin Flaps against Ischemia/Reperfusion Injury via IL-6 Expression | Pu C.-M.; Liu C.-W.; Liang C.-J.; Yen Y.-H.; Chen S.-H.; Jiang-Shieh Y.-F.; Chien C.-L.; Chen Y.-C.; YUH-LIEN CHEN | Journal of Investigative Dermatology | 84 | 81 | |
| 2017 | Adipose-Derived Stem Cells Protect Skin Flaps against Ischemia/Reperfusion Injury via IL-6 Expression | Pu C.-M.; Liu C.-W.; Liang C.-J.; Yen Y.-H.; Chen S.-H.; Jiang-Shieh Y.-F.; CHUNG-LIANG CHIEN ; Chen Y.-C.; Chen Y.-L. | Journal of Investigative Dermatology | 84 | 81 | |
| 2021 | Chronic hepatitis B exhibited higher rate of hepatocellular carcinoma occurrence than hepatitis C in cirrhotic patients after effective antiviral treatment | Lin M.-T.; Chang K.-C.; Yen Y.-H.; Tsai M.-C.; CHIEN-HUNG CHEN ; Wang J.-H.; Hsiao C.-C.; Chiu Y.-H.; Hu T.-H. | Journal of the Formosan Medical Association | 0 | 1 | |
| 2021 | Corrigendum: Real-World Lenvatinib Versus Sorafenib in Patients With Advanced Hepatocellular Carcinoma: A Propensity Score Matching Analysis (Front. Oncol., (2021), 11, (737767), 10.3389/fonc.2021.737767) | Kuo Y.-H.; Lu S.-N.; Chen Y.-Y.; Kee K.-M.; Yen Y.-H.; Hung C.-H.; Hu T.-H.; CHIEN-HUNG CHEN ; Wang J.-H. | Frontiers in Oncology | 1 | 0 | |
| 2018 | Curcumin accelerates cutaneous wound healing via multiple biological actions: The involvement of TNF-α, MMP-9, α-SMA, and collagen | Yen Y.-H.; Pu C.-M.; Liu C.-W.; Chen Y.-C.; Chen Y.-C.; Liang C.-J.; JUNG-HSIEN HSIEH ; Huang H.-F.; Chen Y.-L. | International Wound Journal | 45 | 46 | |
| 2018 | Curcumin accelerates cutaneous wound healing via multiple biological actions: The involvement of TNF-α, MMP-9, α-SMA, and collagen | Yen Y.-H.; Pu C.-M.; Liu C.-W.; Chen Y.-C.; Chen Y.-C.; Liang C.-J.; Hsieh J.-H.; Huang H.-F.; YUH-LIEN CHEN | International Wound Journal | 45 | 46 | |
| 2020 | Intensive care unit-acquired weakness | Siao S.-F.; Yen Y.-H.; Yu Y.-F.; Zong S.-L.; CHERYL CHIA-HUI CHEN | Journal of Nursing | 0 | 0 | |
| 2019 | Interleukin-6 from Adipose-Derived Stem Cells Promotes Tissue Repair by the Increase of Cell Proliferation and Hair Follicles in Ischemia/Reperfusion-Treated Skin Flaps | Pu C.-M.; Chen Y.-C.; Chen Y.-C.; Lee T.-L.; Peng Y.-S.; Chen S.-H.; Yen Y.-H.; Chien C.-L.; Hsieh J.-H.; YUH-LIEN CHEN | Mediators of Inflammation | 8 | 9 | |
| 2019 | Interleukin-6 from Adipose-Derived Stem Cells Promotes Tissue Repair by the Increase of Cell Proliferation and Hair Follicles in Ischemia/Reperfusion-Treated Skin Flaps | Pu C.-M.; Chen Y.-C.; Chen Y.-C.; Lee T.-L.; Peng Y.-S.; Chen S.-H.; Yen Y.-H.; Chien C.-L.; JUNG-HSIEN HSIEH ; Chen Y.-L. | Mediators of Inflammation | 8 | 9 | |
| 2019 | Interleukin-6 from Adipose-Derived Stem Cells Promotes Tissue Repair by the Increase of Cell Proliferation and Hair Follicles in Ischemia/Reperfusion-Treated Skin Flaps | Pu C.-M.; Chen Y.-C.; Chen Y.-C.; Lee T.-L.; Peng Y.-S.; Chen S.-H.; Yen Y.-H.; CHUNG-LIANG CHIEN ; Hsieh J.-H.; Chen Y.-L. | Mediators of Inflammation | 8 | 9 | |
| 2020 | A phase I study of pexidartinib, a colony-stimulating factor 1 receptor inhibitor, in Asian patients with advanced solid tumors | Lee J.-H.; Chen T.W.-W.; CHIH-HUNG HSU ; Yen Y.-H.; Yang J.C.-H.; Cheng A.-L.; Sasaki S.-I.; Chiu L.Y.; Sugihara M.; Ishizuka T.; Oguma T.; Tajima N.; Lin C.-C. | Investigational New Drugs | 26 | 24 | |
| 2020 | A phase I study of pexidartinib, a colony-stimulating factor 1 receptor inhibitor, in Asian patients with advanced solid tumors | JIH-HSIANG LEE ; Chen T.W.-W.; Hsu C.-H.; Yen Y.-H.; Yang J.C.-H.; Cheng A.-L.; Sasaki S.-I.; Chiu L.Y.; Sugihara M.; Ishizuka T.; Oguma T.; Tajima N.; Lin C.-C. | Investigational New Drugs | 26 | 24 | |
| 2020 | A phase I study of pexidartinib, a colony-stimulating factor 1 receptor inhibitor, in Asian patients with advanced solid tumors | Lee J.-H.; Chen T.W.-W.; Hsu C.-H.; Yen Y.-H.; Yang J.C.-H.; ANN-LII CHENG ; Sasaki S.-I.; Chiu L.Y.; Sugihara M.; Ishizuka T.; Oguma T.; Tajima N.; Lin C.-C. | Investigational New Drugs | 26 | 24 | |
| 2020 | A phase I study of pexidartinib, a colony-stimulating factor 1 receptor inhibitor, in Asian patients with advanced solid tumors | Lee J.-H.; WEI-WU CHEN ; Hsu C.-H.; Yen Y.-H.; Yang J.C.-H.; Cheng A.-L.; Sasaki S.-I.; Chiu L.Y.; Sugihara M.; Ishizuka T.; Oguma T.; Tajima N.; Lin C.-C. | Investigational New Drugs | 26 | 24 | |
| 2015 | A polymorphism in interferon L3 Is an independent risk factor for development of hepatocellular carcinoma after treatment of hepatitis c virus infection | Chang K.-C.; Tseng P.-L.; Wu Y.-Y.; Hung H.-C.; Huang C.-M.; Lu S.-N.; Wang J.-H.; Lee C.-M.; Chen C.-H.; Tsai M.-C.; Yen Y.-H.; Lin M.-T.; Wu C.-K.; Huang C.-C.; Chen, Tony Hsiu Hsi ; Hu T.-H. | Clinical Gastroenterology and Hepatology | 46 | 46 | |
| 2021 | Real-World Lenvatinib Versus Sorafenib in Patients With Advanced Hepatocellular Carcinoma: A Propensity Score Matching Analysis | Kuo Y.-H.; Lu S.-N.; Chen Y.-Y.; Kee K.-M.; Yen Y.-H.; Hung C.-H.; Hu T.-H.; CHIEN-HUNG CHEN ; Wang J.-H. | Frontiers in Oncology | 0 | 1 | |
| 2004 | Serum and endometrial markers | Yang W.-C.V.; HUEI-WEN CHEN ; Au H.-K.; Chang C.-W.; Huang C.-T.; Yen Y.-H.; Tzeng C.-R. | Best Practice and Research: Clinical Obstetrics and Gynaecology | 35 | 27 | |
| 2011 | Sex differences in conscious sedation during upper gastrointestinal panendoscopic examination | Yen Y.-H.; Lin T.-F.; Lin C.-J.; YI-CHIA LEE ; Lau H.-P.; Yeh H.-M. | Journal of the Formosan Medical Association | 4 | 5 | |
| 2021 | Statin use is associated with a lower risk of recurrence after curative resection in BCLC stage 0-A hepatocellular carcinoma | Yang S.-Y.; Wang C.-C.; Chen K.-D.; Liu Y.-W.; Lin C.-C.; Chuang C.-H.; YU-CHIEH TSAI ; Yao C.-C.; Yen Y.-H.; Hsiao C.-C.; Hu T.-H.; Tsai M.-C. | BMC Cancer | 4 | 4 | |
| 2013 | Thalidomide inhibits fibronectin production in TGF-β1-treated normal and keloid fibroblasts via inhibition of the p38/Smad3 pathway | Liang C.-J.; Yen Y.-H.; Hung L.-Y.; SHU-HUEI WANG ; Pu C.-M.; Chien H.-F.; Tsai J.-S.; Lee C.-W.; Yen F.-L.; Chen Y.-L. | Biochemical Pharmacology | 32 | 29 | |
